CURE’s myeloma page is a go-to resource for oncology news and updates in the world of myeloma Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in myeloma.
Cristina Gasparetto, MD, gives a brief overview of the multiple myeloma disease state and introduces us to Donna, one of her patients diagnosed with multiple myeloma.
December 15th 2019
At CURE’s Educated Patient Summit on Multiple Myeloma, Dr. Barry Paul discussed the role of minimal residual disease measurement and how it may be used in the future to determine treatment options for patients with myeloma.
December 15th 2019
Dr. Cesar Rodriguez offers a message of hope and self-determination for patients with multiple myeloma.
December 11th 2019
Expanding a combination from two drugs to three may lengthen the time until disease progression for patients with relapsed or refractory multiple myeloma.
December 8th 2019
A dual-targeted chimeric antigen receptor-T cell therapy showed a more than 90% overall response rate in patients with relapsed or refractory disease.
December 7th 2019
JNJ-4528 showed deep responses and proved to be safe in patients with multiple myeloma, according to CARTITUDE-1 study findings.
December 7th 2019
As patients progress through therapy, it is important that oncologists not disregard the novel agents that are currently being investigated in clinical trials, according to Memorial Sloan Kettering Cancer Center’s Dr. Sham Mailankody.
November 27th 2019
Meet four patients with multiple myeloma who have found hope and improved quality of life by participating in endurance events.
November 8th 2019
From new data released about CRISPR technology’s safety to Will Smith sharing his colonoscopy with the world, here’s what is making headlines in the cancer space this week.
October 17th 2019
College football anchor Rod Gilmore uses his voice to help raise awareness following a multiple myeloma diagnosis.
September 27th 2019
For Blood Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.
September 26th 2019
The four-drug regimen of Darzalex in combination with Velcade, Thalomid and dexamethasone has been approved for the treatment of newly diagnosed patients with multiple myeloma who are eligible for autologous stem cell transplant.
September 25th 2019
Here’s a look at what’s inside our 2019 Hematology special issue.
September 19th 2019
After learning to walk again following a life-changing multiple myeloma diagnosis, Richard Bell takes on Mount Washington.
September 19th 2019
Many patients with blood cancers may be candidates for autologous or allogeneic transplant.
September 18th 2019
Receiving supportive care can help ease symptoms of cancer and its treatment, improving quality of life for patients. But many with multiple myeloma are missing out on aspects of this type of care, according to study findings published in Cancer.
September 17th 2019
New technologies boost safety for patients with cancer who need donated blood.
September 9th 2019
Newer treatments for multiple myeloma come with an increased risk for thrombosis, but researchers discovered five factors that could help prevent the side effect.
August 29th 2019
CURE spoke with Ryan Anthony, a Dallas Symphony trumpet player, about how his passion for music led to his myeloma diagnosis and the start of his foundation CancerBlows.
August 16th 2019
From an FDA warning to real-life superheroes, here’s what is making headlines in the cancer space this week.
August 2nd 2019
From today’s top performers and athletes to medical aid in dying, here’s what is making headlines in the cancer space this week.
July 19th 2019
Researchers examined what goes into treatment decision-making for patients with multiple myeloma.
July 9th 2019
The use of Darzalex in combination with Revlimid, Velcade and Ozurdex demonstrated a higher percentage of stringent complete responses among transplant eligible, newly diagnosed patients with multiple myeloma.
July 5th 2019
From today’s top performers and athletes to life-threatening social media disinformation, here’s what is making headlines in the cancer space this week.
July 4th 2019
Cancer Blows, an event by The Ryan Anthony Foundation, offers hope for many with cancer – all while raising awareness for multiple myeloma.
July 3rd 2019
The Food and Drug Administration has granted an accelerated approval to Xpovio in combination with dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma who have received more than four prior therapies.
June 28th 2019
The FDA has approved the combination of Darzalex with Revlimid and dexamethasone (DRd) for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation.
June 26th 2019
The Food and Drug Administration lifted a partial clinical hold on the CANOVA trial, examining Venclexta plus dexamethasone for some patients with relapsed/refractory myeloma.
June 24th 2019
In the second part of our Q&A with Chris Williams, of the Multiple Myeloma Research Foundation, we spoke with him about the past, present and future of the myeloma landscape.
June 20th 2019
In the first part of our Q&A with Chris Williams, of the Multiple Myeloma Research Foundation, we spoke with him on the current initiatives and resources available to patients.
June 10th 2019
Researchers determined that having difficulty performing at least one instrumental activity of daily living puts older patients at risk of death, unplanned hospitalization and emergency department visits.